📰 Dexcom Inc News
Dexcom Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dexcom Inc. Real-time updates on events, politics, business and more.
June 13, 2024
MayTech Global Investments LLC grew its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 0.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 162,852 shares of the medical device company’s stock after purchasing an additional 1,151 shares during the […]
June 12, 2024
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) CFO Jereme M. Sylvain sold 745 shares of the company’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $115.05, for a total transaction of $85,712.25. Following the completion of the transaction, the chief financial officer now owns 84,948 shares […]
June 12, 2024
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) EVP Sadie Stern sold 427 shares of DexCom stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $115.05, for a total transaction of $49,126.35. Following the sale, the executive vice president now directly owns 75,877 shares of the […]
June 12, 2024
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) EVP Sadie Stern sold 427 shares of the stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $115.05, for a total transaction of $49,126.35. Following the completion of the sale, the executive vice president now directly owns 75,877 shares in […]
June 11, 2024
Abbott Laboratories received U.S. FDA clearance for its Lingo and Libre Rio over-the-counter continuous glucose monitoring systems, enabling it to challenge Dexcom Inc. in this rapidly growing market. Dexcom received FDA clearance for its OTC Stela continuous glucose monitor in March.
June 9, 2024
Natixis Investment Managers International lowered its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 9.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 219,638 shares of the medical device company’s stock after selling 22,094 shares during the quarter. DexCom makes up […]
June 7, 2024
Cibc World Markets Corp raised its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 59.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 105,232 shares of the medical device company’s stock after acquiring an additional […]
June 7, 2024
Cibc World Markets Corp raised its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 59.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 105,232 shares of the medical device company’s stock after acquiring an additional […]
June 7, 2024
Angeles Investment Advisors LLC raised its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 13.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,953 shares of the medical device company’s stock after buying an additional 929 shares during […]
June 5, 2024
Capital World Investors lifted its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 130.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,278,685 shares of the medical device company’s stock after acquiring an additional 5,256,092 shares during […]